Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EBT (2022 - 2025)

Historic EBT for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to -$92152.0.

  • Cannabis Bioscience International Holdings' EBT rose 779.54% to -$92152.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$552335.0, marking a year-over-year increase of 110.37%. This contributed to the annual value of -$557627.0 for FY2025, which is 1291.79% up from last year.
  • Latest data reveals that Cannabis Bioscience International Holdings reported EBT of -$92152.0 as of Q3 2025, which was up 779.54% from -$237649.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year EBT high stood at -$70827.0 for Q4 2024, and its period low was -$324655.0 during Q1 2023.
  • Moreover, its 4-year median value for EBT was -$166748.0 (2023), whereas its average is -$176105.7.
  • Its EBT has fluctuated over the past 5 years, first surged by 5475.04% in 2024, then plummeted by 9021.66% in 2025.
  • Over the past 4 years, Cannabis Bioscience International Holdings' EBT (Quarter) stood at -$219886.0 in 2022, then surged by 43.41% to -$124428.0 in 2023, then surged by 43.08% to -$70827.0 in 2024, then crashed by 30.11% to -$92152.0 in 2025.
  • Its EBT was -$92152.0 in Q3 2025, compared to -$237649.0 in Q2 2025 and -$151707.0 in Q1 2025.